Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism
Despite the high number of drugs taken that could potentially interact with apixaban, none were found to clearly influence clinical outcomes, except that fluconazole may increase the risk of CRNMB.
Authors
- Anders Erik Astrup Dahm (ORCID: https://orcid.org/0000-0003-4477-3526)
- Tone Enden (ORCID: https://orcid.org/0000-0003-4578-5887)
- Per Morten Sandset (ORCID: https://orcid.org/0000-0001-5556-8099)
- Jorunn Brekke (ORCID: https://orcid.org/0000-0002-0691-874X)
- Elin Osvik Velle (ORCID: https://orcid.org/0000-0003-0059-1130)
- Marte Svalastoga
- Alina Carmen Porojnicu (ORCID: https://orcid.org/0000-0002-6670-8699)
- Hilde Skuterud Wik (ORCID: https://orcid.org/0000-0002-1035-5521)
- Herish Garresori (ORCID: https://orcid.org/0000-0002-8811-7523)
- Waleed Ghanima (ORCID: https://orcid.org/0000-0003-2225-6165)
- Anne Hansen Ree (ORCID: https://orcid.org/0000-0002-8264-3223)
- Hege Frøen (ORCID: https://orcid.org/0000-0003-4041-389X)
- E. Jacobsen (ORCID: https://orcid.org/0000-0002-9150-5682)
- Dag Torfoss
- Trine‐Lise Larsen (ORCID: https://orcid.org/0000-0001-7776-7849)
Institutions
- Oslo University Hospital (NO)
- University of Oslo (NO)
- Volda University College (NO)
- Stavanger University Hospital (NO)
- Akershus University Hospital (NO)
- Drammen Hospital (NO)
- Vestre Viken Hospital Trust (NO)
- Haukeland University Hospital (NO)
- Østfold Hospital Trust (NO)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-01-27
- DOI
- https://doi.org/10.3389/fonc.2025.1520725
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00